Moreover, it has been shown that cystatin-C is an independent risk factor in the prognosis of patients with HF [56] and has a significant prognostic value in patients with HF and an ejection fraction (EF) of left ventricle >40% and in stable HF patients who had a lower EF <35% [57]. This evidence concerns the gene CST3 and hydrops fetalis.